drugset / Trial / NCT00759811

METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)

NCT00759811

Phase 2/3 Completed 50 enrolled Instituto de Cardiologia do Rio Grande do Sul
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to evaluate the efficacy of methotrexate to improve physical capacity in patients with symptomatic ischemic heart failure.

Timeline

Start
2007-12
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 7.5 mg Oral
Background folic acid Other / unclassified 5 mg Oral